Drug Search Results

Tacalcitol

Alternative Names: tacalcitol
Latest Update: 2024-12-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: IL6 Inhibitor,IL8 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Antonio Noda Cabrera
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tacalcitol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Vitiligo

Phase 3: Psoriasis

Trial	Phase	Trial Status	Disease	Primary Completion Date
n.a.	P3	Completed	Psoriasis	2007-06-08
2004-003215-22	P4	Active, not recruiting	Vitiligo	2004-09-27
JapicCTI-090871	P3	Completed	Psoriasis	None

Recent News Events

Date	Type	Title
12/01/2024	PubMed	Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis.
10/01/2023	PubMed	Noncorticosteroid Topical Therapies for the Treatment of Plaque Psoriasis: A Narrative Review.
09/30/2023	PubMed	Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review.
03/22/2023	News Article	Biologics Market Size Worth USD 710.53 Billion by 2030 at 7.6% CAGR – Report by Market Research Future (MRFR)
11/03/2022	News Article	Light Therapy Market Size Worth USD 1112.16 Million by 2030 at 5.10% CAGR – Report by Market Research Future (MRFR)
12/09/2020	News Article	Psoriasis Treatment Market Size Projection, Latest Trends, Growth Estimation, Share Value and Future Insights By 2025
02/12/2020	News Article	Psoriasis Drugs Market Size Is Projected to Reach USD 13.1 Billion at a CAGR of 7.3% By 2025

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions